糖尿病患者中高血压的发病率远远高于普通人群。随着血压的增高，糖尿病患者并发症的危险性均加倍。对于糖尿病合并高血压（DM合并HT）的治疗，文献较为一致地肯定血管紧张素转换酶抑制剂（ACEI）和钙括抗剂（CCB）作为首选药物。问题在于使用这二类药物后对肾功能及胰岛分泌功 The incidence of hypertension in diabetic patients is much higher than the general population. As blood pressure increases, the risk of diabetic complications are doubled. For the treatment of diabetes with hypertension (DM combined with HT), the literature more consistently affirmed the angiotensin converting enzyme inhibitor (ACEI) and calcium antagonist (CCB) as the drug of choice. The problem is that after using these two drugs on renal function and pancreatic islet function